These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6338207)

  • 1. Circulating prostacyclin metabolites in the dog.
    Taylor BM; Shebuski RJ; Sun FF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):692-8. PubMed ID: 6338207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution and biliary excretion of prostacyclin metabolites in the rat.
    Taylor BM; Sun FF
    J Pharmacol Exp Ther; 1980 Jul; 214(1):24-30. PubMed ID: 6993658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin metabolites in human plasma.
    Rosenkranz B; Fischer C; Frölich JC
    Clin Pharmacol Ther; 1981 Mar; 29(3):420-4. PubMed ID: 7009022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic disposition of prostacyclin in humans.
    Brash AR; Jackson EK; Saggese CA; Lawson JA; Oates JA; FitzGerald GA
    J Pharmacol Exp Ther; 1983 Jul; 226(1):78-87. PubMed ID: 6345756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low levels of 6-keto-prostaglandin F1 alpha in human plasma.
    Siess W; Dray F
    J Lab Clin Med; 1982 Mar; 99(3):388-98. PubMed ID: 7035588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
    Rosenkranz B; Fischer C; Reimann I; Weimer KE; Beck G; Frölich JC
    Artery; 1980; 8(1):18-22. PubMed ID: 7000039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
    Bothwell W; Verburg M; Wynalda M; Daniels EG; Fitzpatrick FA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):229-35. PubMed ID: 6948952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and effective conversion of 6-keto-prostaglandin F1 alpha to 6,15-diketo-13, 14-dihydro-prostaglandin F1 alpha-immunoreactive material in vivo.
    Förstermann U; Neufang B; Hertting G
    Prostaglandins Leukot Med; 1982 Sep; 9(3):277-84. PubMed ID: 6752956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK; Goodman RP; Fitzgerald GA; Oates JA; Branch RA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):183-7. PubMed ID: 7038095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma.
    Machleidt C; Förstermann U; Anhut H; Hertting G
    Eur J Pharmacol; 1981 Aug; 74(1):19-26. PubMed ID: 7032951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
    Rosenkranz B; Fischer C; Weimer KE; Frölich JC
    J Biol Chem; 1980 Nov; 255(21):10194-8. PubMed ID: 7000774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of 3H-enisoprost, a gastric antisecretory prostaglandin, in healthy humans.
    Allan LM; Hawkins AJ; Vose CW; Firth J; Brownsill RD; Steiner JA
    Xenobiotica; 1987 Oct; 17(10):1233-46. PubMed ID: 3424870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravitreal and topical prostaglandins on intraocular inflammation.
    Kulkarni PS; Srinivasan BD
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo metabolism of desogestrel in several species.
    Verhoeven CH; Krebbers SF; Wagenaars GN; Vos RM
    Drug Metab Dispos; 1998 Sep; 26(9):927-36. PubMed ID: 9733673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
    Vainio M; Riutta A; Koivisto AM; Mäenpää J
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1119-23. PubMed ID: 15548142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of urinary PGEm, 6-keto PGF(1alpha) and 2,3-dinor-6-keto PGF(1alpha) by UFLC-MS/MS before and after exercise.
    Blatnik M; Steenwyk RC
    Prostaglandins Other Lipid Mediat; 2010 Sep; 93(1-2):8-13. PubMed ID: 20416393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of prostacyclin in rat.
    Sun FF; Taylor BM
    Biochemistry; 1978 Sep; 17(19):4096-101. PubMed ID: 361075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
    Ylikorkala O; Saarela E; Viinikka L
    J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and characterization of the subtypes(s) of muscarinic receptor involved in prostacyclin synthesis in rabbit heart.
    Kan H; Ruan Y; Malik K U
    J Pharmacol Exp Ther; 1996 Mar; 276(3):934-41. PubMed ID: 8786573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.